PTAB Upholds Entirety Of 3 Narcan Patents
The Patent Trial and Appeal Board has refused to invalidate three different patents covering Adapt Pharma Ltd.'s opioid overdose treatment Narcan, two of which had a different fate in district court....To view the full article, register now.
Already a subscriber? Click here to view full article